课题基金 / 基金详情

GUTLAB – A SMART PILL FOR REMOTE HEALTH MONITORING VIA THE GUT MICROBIOME

GUTLAB – A SMART PILL FOR REMOTE HEALTH MONITORING VIA THE GUT MICROBIOME
GUTLAB — 通过肠道微生物组进行远程健康监测的智能药丸
批准号:
53074
负责人:
金额:
$14.89万
依托单位:
依托单位国家:
英国
项目类别:
Study
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
肠经济学正在通过开发一种平台,通过肠道微生物群实现远程健康监测,来解决长寿这一尚未得到满足的挑战。肠道微生物群对健康至关重要--它影响你的新陈代谢、免疫系统,甚至大脑功能。我们吃的食物、药物、锻炼、睡眠和压力都会影响肠道微生物群,并可能导致肠道微生物群被破坏,导致许多疾病,如肥胖症、肠道问题,甚至阿尔茨海默氏症。Enterology正在提供一种可食用的智能传感药丸,它可以跟踪微生物群,并实时向智能手机应用程序提供反馈。Enterology是一家初创公司,由材料科学家菲比·赫塞尔廷和生物技术专家玛丽亚姆·埃尔加布里于2019年创立。他们正在开发一系列智能药丸来监测和检测慢性疾病,从炎症性肠病(IBD)开始。通过这一创新的英国Smart Grant,这种可食用设备的核心部件--通过联合创始人的初步研究开发--将与伦敦大学学院合作进行安全性和性能评估。在这笔赠款中开展的工作是发展强大的知识产权地位和确定下一步制造的关键,这将使Enterology能够将这项技术推向市场。锻炼、营养、睡眠和其他生活方式因素以及提供的药物治疗对肠道微生物群有直接影响,这为通过持续微生物群监测更好地管理慢性病提供了机会之窗。如果成功,这项技术将超过现有的微生物群采样方法,如粪便采样,这些方法不方便、昂贵且见效慢。该产品将首先在英国推出,服务于IBD患者。IBD是一种慢性复发性胃肠道疾病,目前尚无治愈方法。英国的IBD患病率位居世界第二,每年花费NHS GB 7.2亿英镑。在英国成功推出这项技术后,这项技术将在北美销售,北美是可食用传感器和微生物产品增长最快的市场。许多患者在突发疾病时寻求重复的医疗护理,经常进行侵入性体检,开出无效的治疗处方和手术。在IBD患者中,肠道微生物群的变化与疾病的突发之间存在着非常密切的联系。有了企业组学公司的技术,个人将能够以一种医疗上安全、方便和有效的方式监测自己的病情。企业经济学认为,他们的技术正在扩展到其他慢性病的管理以及消费者应用领域。
英文摘要
Enteromics are addressing the unmet challenge of longevity through developing a platform that enables remote health monitoring via the gut microbiome. The gut microbiome is crucial to health -- it affects your metabolism, immune system and even brain function. The food we eat, medications, exercise, sleep and stress all affect the gut microbiome and can cause it to become disrupted, leading to many diseases such as obesity, gut problems and even Alzheimer's. Enteromics is providing an ingestible smart sensing pill that tracks the microbiome and provides feedback to a smartphone App, in real-time.Enteromics is a start-up founded in 2019 by Phoebe Heseltine, a materials scientist and Mariam Elgabry, a biotechnologist. They are developing a range of smart pills to monitor and detect chronic diseases, beginning with Inflammatory Bowel Disease (IBD).Through this innovate UK Smart Grant, the core components of the ingestible device -- developed through the co-founders' initial research -- will be evaluated for safety and performance, in partnership with University College London. The work carried out in this grant is key to developing a strong IP position and determining the next steps to manufacturing, which will enable Enteromics to bring this technology to market.Exercise, nutrition, sleep and other lifestyle factors, as well as drug treatments offered, have an immediate effect on the gut microbiome and this provides a window of opportunity for better management of chronic conditions through continuous microbiome monitoring. If successful, the technology will outperform existing methods of sampling the microbiome such as faecal sampling, which are inconvenient, expensive and slow to provide results.The product will first launch in the UK to serve sufferers of IBD, a chronic relapsing gastrointestinal disorder for which there is no cure. IBD prevalence in the UK is second highest in the world, costing the NHS £720 million a year. Following successful launch in the UK the technology will be sold in North America, the fastest growing market for both ingestible sensors and microbiome products.Many sufferers seek repeated medical care for flare-ups, with frequent invasive medical exams, prescription of ineffective treatments and surgery. In IBD patients there is a very strong link between gut microbiome changes and disease flare-ups. With Enteromics' technology, individuals will be able to monitor their condition in a way that is medically safe, convenient and effective. Enteromics see their technology expanding into management of other chronic conditions as well as in consumer applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于SMART技术的鳄梨叶中诱导肿瘤细胞铁死亡的先导化合物的定 向挖掘
基于“活性-代谢组-基因组-SMART”整合策略发掘老鼠簕内生放线菌新型先导化合物
  • 批准号:
    82360696
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    卢覃培
  • 依托单位:
特定微环境激活的mRNA翻译(SMART)系统的设计及其免疫治疗应用研究
基于ANDSystem与多组学的水稻和小麦胁迫响应分子调控网络及智能作物平台(Smart Crop)的构建
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    105万元
  • 批准年份:
    2022
  • 负责人:
    陈铭
  • 依托单位: